These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26088929)

  • 21. MIR125B1 represses the degradation of the PML-RARA oncoprotein by an autophagy-lysosomal pathway in acute promyelocytic leukemia.
    Zeng CW; Chen ZH; Zhang XJ; Han BW; Lin KY; Li XJ; Wei PP; Zhang H; Li Y; Chen YQ
    Autophagy; 2014 Oct; 10(10):1726-37. PubMed ID: 25126724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences.
    Grisolano JL; Wesselschmidt RL; Pelicci PG; Ley TJ
    Blood; 1997 Jan; 89(2):376-87. PubMed ID: 9002938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemia.
    Walz C; Grimwade D; Saussele S; Lengfelder E; Haferlach C; Schnittger S; Lafage-Pochitaloff M; Hochhaus A; Cross NC; Reiter A
    Genes Chromosomes Cancer; 2010 May; 49(5):471-9. PubMed ID: 20155840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The deubiquitinating enzyme USP37 regulates the oncogenic fusion protein PLZF/RARA stability.
    Yang WC; Shih HM
    Oncogene; 2013 Oct; 32(43):5167-75. PubMed ID: 23208507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells.
    Duprez E; Wagner K; Koch H; Tenen DG
    EMBO J; 2003 Nov; 22(21):5806-16. PubMed ID: 14592978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a 3-Plex RT-qPCR assay for the simultaneous detection and quantitation of the three PML-RARa fusion transcripts in acute promyelocytic leukemia.
    Chen Z; Tong Y; Li Y; Gao Q; Wang Q; Fu C; Xia Z
    PLoS One; 2015; 10(3):e0122530. PubMed ID: 25815789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression and function of PML-RARA in the hematopoietic progenitor cells of Ctsg-PML-RARA mice.
    Wartman LD; Welch JS; Uy GL; Klco JM; Lamprecht T; Varghese N; Nagarajan R; Ley TJ
    PLoS One; 2012; 7(10):e46529. PubMed ID: 23056333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.
    Lucena-Araujo AR; Coelho-Silva JL; Pereira-Martins DA; Thomé C; Scheucher PS; Lange AP; Paiva HH; Hemmelgarn BT; Morais-Sobral MC; Azevedo EA; Franca-Neto PL; Franca RF; Silva CL; Krause A; Rego EM
    Oncotarget; 2017 Jan; 8(5):8475-8483. PubMed ID: 28035072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a molecular signature for leukemic promyelocytes and their normal counterparts: Focus on DNA repair genes.
    Casorelli I; Tenedini E; Tagliafico E; Blasi MF; Giuliani A; Crescenzi M; Pelosi E; Testa U; Peschle C; Mele L; Diverio D; Breccia M; Lo-Coco F; Ferrari S; Bignami M
    Leukemia; 2006 Nov; 20(11):1978-88. PubMed ID: 16990782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PML-RARA fusion resulting from a cryptic insertion of RARA gene into PML gene without the reciprocal RARA-PML fusion: clinical, cytogenetic, and molecular characterization and prognosis.
    Fan H; Ortega V; Fanasch HM; Wang Y; Holder KN; Higgins RA; Mendiola C; Mohamed G; Vadlamudi K; Velagaleti G
    Eur J Haematol; 2014 Oct; 93(4):354-8. PubMed ID: 24673420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Detection of PML/RARa transcripts in acute promyelocytic leukemia by real-time quantitative reverse transcription polymerase chain reaction].
    Lang L; Li HM; Liu H; Wang YM; Zhang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):714-9. PubMed ID: 17708789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-operative leukemogenesis in acute myeloid leukemia and acute promyelocytic leukemia reveals C/EBPα as a common target of TRIB1 and PML/RARA.
    Keeshan K; Vieugué P; Chaudhury S; Rishi L; Gaillard C; Liang L; Garcia E; Nakamura T; Omidvar N; Kogan SC
    Haematologica; 2016 Oct; 101(10):1228-1236. PubMed ID: 27390356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3.
    Jeanne M; Lallemand-Breitenbach V; Ferhi O; Koken M; Le Bras M; Duffort S; Peres L; Berthier C; Soilihi H; Raught B; de Thé H
    Cancer Cell; 2010 Jul; 18(1):88-98. PubMed ID: 20609355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone morphogenetic proteins regulate differentiation of human promyelocytic leukemia cells.
    Topić I; Ikić M; Ivčević S; Kovačić N; Marušić A; Kušec R; Grčević D
    Leuk Res; 2013 Jun; 37(6):705-12. PubMed ID: 23528261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity.
    Noguera NI; Piredda ML; Taulli R; Catalano G; Angelini G; Gaur G; Nervi C; Voso MT; Lunardi A; Pandolfi PP; Lo-Coco F
    Oncotarget; 2016 Oct; 7(41):66386-66397. PubMed ID: 27626703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.
    Guibal FC; Alberich-Jorda M; Hirai H; Ebralidze A; Levantini E; Di Ruscio A; Zhang P; Santana-Lemos BA; Neuberg D; Wagers AJ; Rego EM; Tenen DG
    Blood; 2009 Dec; 114(27):5415-25. PubMed ID: 19797526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The lncRNA HOTAIRM1 regulates the degradation of PML-RARA oncoprotein and myeloid cell differentiation by enhancing the autophagy pathway.
    Chen ZH; Wang WT; Huang W; Fang K; Sun YM; Liu SR; Luo XQ; Chen YQ
    Cell Death Differ; 2017 Feb; 24(2):212-224. PubMed ID: 27740626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PML-RARa modulates the vascular signature of extracellular vesicles released by acute promyelocytic leukemia cells.
    Fang Y; Garnier D; Lee TH; D'Asti E; Montermini L; Meehan B; Rak J
    Angiogenesis; 2016 Jan; 19(1):25-38. PubMed ID: 26374632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PML-RARA requires DNA methyltransferase 3A to initiate acute promyelocytic leukemia.
    Cole CB; Verdoni AM; Ketkar S; Leight ER; Russler-Germain DA; Lamprecht TL; Demeter RT; Magrini V; Ley TJ
    J Clin Invest; 2016 Jan; 126(1):85-98. PubMed ID: 26595813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia.
    Lee GY; Christina S; Tien SL; Ghafar AB; Hwang W; Lim LC; Lim TH
    Cancer Genet Cytogenet; 2005 Jun; 159(2):129-36. PubMed ID: 15899384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.